CHCHD4 and pulmonary arterial hypertension: In current study, we uncovered that CHCHD4 promoted mitochondrial oxidative phosphorylation and blunted PASMCs’ aberrant proliferation and migration, by which CHCHD4 upregulation attenuated hypoxic PAH phenotype.